Our doctors design personalized protocols and adjust duration based on sleep quality assessments and your wellness objectives
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
post-workout schedule
Designed for enhanced stability relative to the native hGH sequence, and well-characterised as a reference compound in research examining lipid metabolism pathway interactions and adipose tissue signalling dynamics
If a clinic offers injectable GHK-Cu, BPC-157, or TB-500, that route depends on compounding rules, which were in flux in 2026, and is distinct from using an FDA-approved drug